Brief Report: Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples

Epidemiology

Volumn 26, Issue 4, 2015, Pages 597-600

  Alshaarawy, Omayma ^a   Anthony, James C ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANNABIS SMOKING; CONFIDENCE INTERVAL; DIABETES MELLITUS; EXAMINATION; HEALTH SURVEY; HUMAN; INTERVIEW; META ANALYSIS; NUTRITION; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH; REGRESSION ANALYSIS; RISK; TRANSLATIONAL RESEARCH; ADULT; FEMALE; MALE; MIDDLE AGED; ODDS RATIO; STATISTICAL MODEL; UNITED STATES; YOUNG ADULT;

ADULT; DIABETES MELLITUS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MARIJUANA SMOKING; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; UNITED STATES; YOUNG ADULT;

EID: 84942783757     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000314     Document Type: Article

References (22)

1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840-846.
2. Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013;17:475-490.
3. O sei-Hyiaman D, DePetrillo M, Pacher P, et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest. 2005;115:1298-1305.
4. Rajavashisth TB, Shaheen M, Norris KC, et al. Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open 2012;2:e000494.
5. P enner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med. 2013;126:583-589.
6. Le Strat Y, Le Foll B. Obesity and cannabis use: results from 2 representative national surveys. Am J Epidemiol. 2011;174:929-933.
7. Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370:2219-2227.
8. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033-1046.
9. United States Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: http://wwwn.cdc.gov/nchs/nhanes/search/nhanes09-10.aspx. Accessed January 11, 2015.
10. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No.(SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012.
11. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(1 suppl):S11-S61.
12. Willett JB, Singer JD. Investigating onset, cessation, relapse, and recovery: why you should, and how you can, use discrete-time survival analysis to examine event occurrence. J Consult Clin Psychol. 1993;61:952-965.
13. E sser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141-150.
14. Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38:183-191.
15. P radhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-334.
16. R ibeiro A, Ferraz-de-Paula V, Pinheiro ML, et al. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor. Eur J Pharmacol. 2012;678:78-85.
17. Alshaarawy O, Anthony JC. Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005-2010. Drug Alcohol Depend. 2015;147:203-207.
18. Weiss L, Zeira M, Reich S, et al. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity. 2006;39:143-151.
19. Mecha M, Feliú A, Iñigo PM, Mestre L, Carrillo-Salinas FJ, Guaza C. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Neurobiol Dis. 2013;59:141-150.
20. Barutta F, Piscitelli F, Pinach S, et al. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy. Diabetes. 2011;60:2386-2396.
21. Croxford JL, Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J Neuroimmunol. 2005;166:3-18.
22. Schicho R, Storr M. Cannabis finds its way into treatment of Crohn's disease. Pharmacology. 2014;93:1-3.